- within Insolvency/Bankruptcy/Re-Structuring and Environment topic(s)
Beatriz San Martin talks about the challenges life sciences companies face today when navigating patent protection. Companies are coming up against concerns about when to file patents; how to protect secondary and further medical uses in Europe, Asia, and the US; and the recent political and social pressure to curtail the scope of patent protection related to covid-19 vaccines.
This is the latest in our series: "Insights: Life Sciences" where we examine the legal issues and trends impacting the life sciences and healthcare industries.
» See the rest of the "Insights: Life Sciences" series here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
